Opsens Inc (TSE:OPS)
Canadian Market

Opsens Inc Stock Analysis & Ratings

TSE:OPS Stock Chart & Stats

Day’s RangeC$0 - C$0
52-Week RangeC$1.55 - C$3.74
Previous CloseC$1.65
Average Volume (3M)192.21K
Market CapC$196.04M
P/E Ratio-31.0
Next EarningsJul 13, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score6
EPS (TTM)-0.06

Opsens Inc News

Currently, no data available
Please return soon. This page is being updated.




P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.



What was Opsens Inc’s price range in the past 12 months?
Opsens Inc lowest stock price was C$1.55 and its highest was C$3.74 in the past 12 months.
    What is Opsens Inc’s market cap?
    Opsens Inc’s market cap is C$196.04M.
      What is Opsens Inc’s price target?
      The average price target for Opsens Inc is C$4.28. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is C$6.00 ,the lowest forecast is C$3.35. The average price target represents 136.46% Increase from the current price of C$1.81.
        What do analysts say about Opsens Inc?
        Opsens Inc’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
          When is Opsens Inc’s upcoming earnings report date?
          Opsens Inc’s upcoming earnings report date is Jul 13, 2022 which is in 58 days.
            How were Opsens Inc’s earnings last quarter?
            Opsens Inc released its earnings results on Apr 13, 2022. The company reported -C$0.02 earnings per share for the quarter, missing the consensus estimate of -C$0.015 by -C$0.005.
              Is Opsens Inc overvalued?
              According to Wall Street analysts Opsens Inc’s price is currently Undervalued.
                Does Opsens Inc pay dividends?
                Opsens Inc does not currently pay dividends.
                What is Opsens Inc’s EPS estimate?
                Opsens Inc’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Opsens Inc have?
                Opsens Inc has 108,310,000 shares outstanding.
                  What happened to Opsens Inc’s price movement after its last earnings report?
                  Opsens Inc reported an EPS of -C$0.02 in its last earnings report, missing expectations of -C$0.015. Following the earnings report the stock price went up 8.38%.
                    Which hedge fund is a major shareholder of Opsens Inc?
                    Currently, no hedge funds are holding shares in TSE:OPS


                    Opsens Inc Stock Analysis

                    Analyst Forecast

                    Strong Buy
                    Average Price Target: C$4.28

                    Blogger Sentiment

                    Currently Not Enough Data Available

                    Hedge Fund Holdings

                    Currently Not Enough Data Available

                    Insider Transactions

                    ▼ Sold Shares
                    Worth C$56.2K over the Last 3 Months

                    Retail Investors

                    Currently Not Enough Data Available

                    News Sentiment

                    Currently Not Enough Data Available


                    20 days / 200 days


                    Return on Equity
                    Trailing 12-Months
                    Asset Growth
                    Trailing 12-Months
                    The Opsens Inc stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Opsens Inc

                    OpSens Inc focuses on interventional cardiology, offering an advanced optical-based pressure guidewire which aims at improving the clinical outcome of patients with coronary artery disease. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and excellent lesions access. The OptoWire has been used in the diagnosis and treatment of over 100,000 patients in more than 30 countries. It is approved for sale in the United States, European Union, Japan, and Canada. OpSens is also involved in industrial activities in developing, manufacturing, and installing innovative fiber optic sensing solutions for critical application.

                    Similar Stocks
                    Price & Change
                    Baylin Tech
                    D-Box Tech Inc. A

                    Popular Stocks

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis